Cell Therapy for Spinal Cord Injury by Neural Stem/Progenitor Cells Derived from iPS/ES Cells

Osahiko Tsuji, Kyoko Miura, Kanehiro Fujiyoshi, Suketaka Momoshima, Masaya Nakamura, Hideyuki Okano

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Reports of functional recovery from spinal cord injury after the transplantation of rat fetus-derived neural stem cells and embryonic stem cells has raised great expectations for the successful clinical use of stem cell transplantation therapy. However, the ethical issues involved in destroying human embryos or fertilized oocytes to obtain stem cells have been a major obstacle to developing clinically useful stem cell sources, and the transplantation of stem cells isolated from other human embryonic tissues has not yet been developed for use in clinical applications. Recently, induced pluripotent stem cells, which can serve as a source of cells for autologous transplantation, have been attracting a great deal of attention as a clinically viable alternative to stem cells obtained directly from tissues. In this review, we outline the neural induction of mouse embryonic stem cells and induced pluripotent stem cells, their therapeutic efficacy in spinal cord injury, and their safety in vivo.

Original languageEnglish
Pages (from-to)668-676
Number of pages9
JournalNeurotherapeutics
Volume8
Issue number4
DOIs
Publication statusPublished - 2011 Oct

Fingerprint

Neural Stem Cells
Cell- and Tissue-Based Therapy
Spinal Cord Injuries
Induced Pluripotent Stem Cells
Stem Cells
Stem Cell Transplantation
Autologous Transplantation
Cell Transplantation
Embryonic Stem Cells
Ethics
Oocytes
Fetus
Embryonic Structures
Transplantation
Safety
Therapeutics

Keywords

  • Cell transplantation
  • Embryonic stem cells
  • Induced pluripotent stem cells
  • Neural differentiation
  • Safety
  • Spinal cord injury

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Pharmacology

Cite this

Cell Therapy for Spinal Cord Injury by Neural Stem/Progenitor Cells Derived from iPS/ES Cells. / Tsuji, Osahiko; Miura, Kyoko; Fujiyoshi, Kanehiro; Momoshima, Suketaka; Nakamura, Masaya; Okano, Hideyuki.

In: Neurotherapeutics, Vol. 8, No. 4, 10.2011, p. 668-676.

Research output: Contribution to journalArticle

@article{0408d4c2b27f407da877d04a3928043c,
title = "Cell Therapy for Spinal Cord Injury by Neural Stem/Progenitor Cells Derived from iPS/ES Cells",
abstract = "Reports of functional recovery from spinal cord injury after the transplantation of rat fetus-derived neural stem cells and embryonic stem cells has raised great expectations for the successful clinical use of stem cell transplantation therapy. However, the ethical issues involved in destroying human embryos or fertilized oocytes to obtain stem cells have been a major obstacle to developing clinically useful stem cell sources, and the transplantation of stem cells isolated from other human embryonic tissues has not yet been developed for use in clinical applications. Recently, induced pluripotent stem cells, which can serve as a source of cells for autologous transplantation, have been attracting a great deal of attention as a clinically viable alternative to stem cells obtained directly from tissues. In this review, we outline the neural induction of mouse embryonic stem cells and induced pluripotent stem cells, their therapeutic efficacy in spinal cord injury, and their safety in vivo.",
keywords = "Cell transplantation, Embryonic stem cells, Induced pluripotent stem cells, Neural differentiation, Safety, Spinal cord injury",
author = "Osahiko Tsuji and Kyoko Miura and Kanehiro Fujiyoshi and Suketaka Momoshima and Masaya Nakamura and Hideyuki Okano",
year = "2011",
month = "10",
doi = "10.1007/s13311-011-0063-z",
language = "English",
volume = "8",
pages = "668--676",
journal = "Neurotherapeutics",
issn = "1933-7213",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Cell Therapy for Spinal Cord Injury by Neural Stem/Progenitor Cells Derived from iPS/ES Cells

AU - Tsuji, Osahiko

AU - Miura, Kyoko

AU - Fujiyoshi, Kanehiro

AU - Momoshima, Suketaka

AU - Nakamura, Masaya

AU - Okano, Hideyuki

PY - 2011/10

Y1 - 2011/10

N2 - Reports of functional recovery from spinal cord injury after the transplantation of rat fetus-derived neural stem cells and embryonic stem cells has raised great expectations for the successful clinical use of stem cell transplantation therapy. However, the ethical issues involved in destroying human embryos or fertilized oocytes to obtain stem cells have been a major obstacle to developing clinically useful stem cell sources, and the transplantation of stem cells isolated from other human embryonic tissues has not yet been developed for use in clinical applications. Recently, induced pluripotent stem cells, which can serve as a source of cells for autologous transplantation, have been attracting a great deal of attention as a clinically viable alternative to stem cells obtained directly from tissues. In this review, we outline the neural induction of mouse embryonic stem cells and induced pluripotent stem cells, their therapeutic efficacy in spinal cord injury, and their safety in vivo.

AB - Reports of functional recovery from spinal cord injury after the transplantation of rat fetus-derived neural stem cells and embryonic stem cells has raised great expectations for the successful clinical use of stem cell transplantation therapy. However, the ethical issues involved in destroying human embryos or fertilized oocytes to obtain stem cells have been a major obstacle to developing clinically useful stem cell sources, and the transplantation of stem cells isolated from other human embryonic tissues has not yet been developed for use in clinical applications. Recently, induced pluripotent stem cells, which can serve as a source of cells for autologous transplantation, have been attracting a great deal of attention as a clinically viable alternative to stem cells obtained directly from tissues. In this review, we outline the neural induction of mouse embryonic stem cells and induced pluripotent stem cells, their therapeutic efficacy in spinal cord injury, and their safety in vivo.

KW - Cell transplantation

KW - Embryonic stem cells

KW - Induced pluripotent stem cells

KW - Neural differentiation

KW - Safety

KW - Spinal cord injury

UR - http://www.scopus.com/inward/record.url?scp=80955142109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80955142109&partnerID=8YFLogxK

U2 - 10.1007/s13311-011-0063-z

DO - 10.1007/s13311-011-0063-z

M3 - Article

VL - 8

SP - 668

EP - 676

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 4

ER -